Ellen Cristina Rivas Leonel

Ellen Cristina Rivas Leonel

Auto-generated profile, based on publicly available information

Ellen Cristina Rivas Leonel

Department of Histology, Embryology and Cell Biology, Institute of Biological Sciences (ICB), Federal University of Goiás (UFG), Goiânia, Brazil

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2019 in Transfusion Medicine and Hemotherapy
Verified
Journal Article
Closed access
PDF file
ELEllen Cristina Rivas Leonel
Ellen Cristina Rivas Leonel
CLCarolina M. Lucci
Carolina M. Lucci
CAChristiani Amorim
Christiani Amorim
Background: Cryopreservation of human ovarian tissue has been increasingly applied worldwide to safeguard fertility in cancer patients, notably in young girls and women who cannot delay the onset of their treatment. Moreover, it has been proposed to patients with benign pathologies with a risk of premature ovarian insufficiency. So far, more than 130 live births have been reported after transplantation of cryopreserved ovarian tissue, and almost all patients recovered their ovarian function after tissue reimplantation. Summary: This review aims to summarize the recent results described in the literature regarding human ovarian tissue cryopreservation in terms of methods and main results obtained so far. To cryopreserve human ovarian tissue, most studies describe a slow freezing/rapid thawing protocol, which is usually an adaptation of a protocol developed for sheep ovarian tissue. Since freezing has been shown to have a deleterious effect on ovarian stroma and granulosa cells, various research groups have been vitrifying ovarian tissue. Despite promising results, only 2 babies have been born after transplantation of vitrified/warmed ovarian tissue. Optimization of both cryopreservation strategies as well as thawing/warming protocols is therefore necessary to improve the survival of follicles in cryopreserved ovarian tissue. Key Messages: Human ovarian tissue cryopreservation has been successfully applied worldwide to preserve fertility in patients with malignant or nonmalignant pathologies that have a detrimental effect on fertility. Human ovarian tissue cryopreservation could also be applied as an alternative to postpone pregnancy or menopause in healthy women. Slow freezing and vitrification procedures have been applied to cryopreserve human ovarian tissue, but both alternatives require optimization.

27 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ELEllen Cristina Rivas Leonel
Ellen Cristina Rivas Leonel
ACAriadna Corral
Ariadna Corral
RRRamon Risco
Ramon Risco
ACAlessandra Camboni
Alessandra Camboni
STSebastiao Roberto Taboga
Sebastiao Roberto Taboga
CAChristiani Amorim
Christiani Amorim
The advantage of stepped vitrification (SV) is avoiding ice crystal nucleation, while decreasing the toxic effects of high cryoprotectant concentrations. We aimed to test this method for human ovarian tissue cryopreservation. Ovarian cortex was taken from 7 fertile adult women. Samples were subjected to an SV protocol performed in an automatic freezer, which allowed sample transfer to ever higher concentrations of dimethyl sulfoxide (DMSO) as the temperature was reduced. Histological evaluation of the vitrified-warmed tissue showed large numbers of degenerated follicles after 24 hours of in vitro culture. We therefore evaluated DMSO perfusion rates by X-ray computed tomography, ice crystal formation by freeze-substitution, and cell toxicity by transmission electron microscopy, seeking possible reasons why follicles degenerated. Although cryoprotectant perfusion was considered normal and no ice crystals were formed in the tissue, ultrastructural analysis detected typical signs of DMSO toxicity, such as mitochondria degeneration, alterations in chromatin condensation, cell vacuolization and extracellular matrix swelling in both stromal and follicular cells. The findings indicated that the method failed to preserve follicles due to the high concentrations of DMSO used. However, adaptations can be made to avoid toxicity to follicles caused by elevated levels of cryoprotectants.

1 February 2019 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
CAChristiani Amorim
Christiani Amorim
ELEllen Cristina Rivas Leonel
Ellen Cristina Rivas Leonel
YAYousri Afifi
Yousri Afifi
ACArri Coomarasamy
Arri Coomarasamy
SFSimon Fishel
Simon Fishel

1 January 2020 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
ELEllen Cristina Rivas Leonel
Ellen Cristina Rivas Leonel
SCSilvana Gisele Pegorin Campos
Silvana Gisele Pegorin Campos
LGLuiz Henrique Alves Guerra
Luiz Henrique Alves Guerra
CBCarolina Marques Bedolo
Carolina Marques Bedolo
PVPatrícia Simone Leite Vilamaior
Patrícia Simone Leite Vilamaior
STSebastiao Roberto Taboga
Sebastiao Roberto Taboga

1 October 2016 in Theriogenology
Verified
Journal Article
Closed access
JVJanice Vilela
Janice Vilela
ELE.C.R. Leonel
E.C.R. Leonel
LDL. D'Oliveira
L. D'Oliveira
RPR.E.G. Paiva
R.E.G. Paiva
AMA.L. Miranda-Vilela
A.L. Miranda-Vilela
CLCarolina Lucci
Carolina Lucci

11 March 2023 in Cell Biology International
Verified
Journal Article
Closed access
TRThalles F. R. Ruiz
Thalles F. R. Ruiz
SCSimone J. Colleta
Simone J. Colleta
Diego Dias dos SantosDiego Dias dos Santos
Diego Dias dos Santos
NCNayara F. C. Castro
Nayara F. C. Castro
ÁCÁgata S. Cabral
Ágata S. Cabral
STSebastiao Roberto Taboga
Sebastiao Roberto Taboga